Lantheus Holdings Inc
LNTH73.880USD
-0.530-0.71%
Horário de mercado （ET）Cotações atrasadas em 15 min
5.11BValor de mercado
20.09P/L TTM
Mais detalhes de Lantheus Holdings Inc Empresa
Lantheus Holdings, Inc. is a radiopharmaceutical-focused company engaged in delivering science to enable clinicians to find, fight and follow diseases to deliver patient outcomes. It classifies its products in three categories: Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships. Radiopharmaceutical Oncology diagnostics and therapeutics help healthcare professionals (HCPs) find, fight and follow cancer, with a focus on prostate cancer. Precision Diagnostic products assist HCPs to find and follow diseases, with a focus on cardiology. Strategic Partnerships focus on enabling precision medicine through the use of biomarker solutions, digital solutions, and radiotherapeutic platforms. Its commercial products include PYLARIFY, DEFINITY, TechneLite, and others. Its clinical candidates include LNTH-2404, NAV-4694, and PNT2002, others. Its OCTEVY is a registrational-stage positron emission tomography (PET) diagnostic imaging agent targeting neuroendocrine tumors.
Informações da empresa
Código da empresaLNTH
Nome da EmpresaLantheus Holdings Inc
Data de listagemJun 25, 2015
Fundado em2007
CEOMr. Brian A. Markison
Número de funcionários808
Tipo de títulosOrdinary Share
Fim do ano fiscalJun 25
Endereço331 Treble Cove Road
CidadeNORTH BILLERICA
Bolsa de valoresNASDAQ Global Market Consolidated
PaísUnited States of America
Código postal01862
Telefone19786718001
Sitehttps://www.lantheus.com/
Código da empresaLNTH
Data de listagemJun 25, 2015
Fundado em2007
Executivos da empresa
Nome
Nome/Posição
Posição
Ações detidas
Variação
Ms. Mary Anne Heino
Ms. Mary Anne Heino
Chairman of the Board
Chairman of the Board
584.72K
-4.27%
Mr. Brian A. Markison
Mr. Brian A. Markison
Chief Executive Officer, Director
Chief Executive Officer, Director
232.42K
+35.31%
Ms. Amanda Morgan
Ms. Amanda Morgan
Chief Commercial Officer
Chief Commercial Officer
39.58K
+55.76%
Dr. Jean-Claude Provost, M.D.
Dr. Jean-Claude Provost, M.D.
Chief Scientific Officer
Chief Scientific Officer
38.84K
-31.55%
Dr. James H. (Jim) Thrall
Dr. James H. (Jim) Thrall
Independent Director
Independent Director
35.74K
+7.64%
Ms. Julie H. Mchugh
Ms. Julie H. Mchugh
Lead Independent Director
Lead Independent Director
25.96K
-16.67%
Dr. Gerard Ber, Ph.D.
Dr. Gerard Ber, Ph.D.
Independent Director
Independent Director
23.36K
+10.09%
Ms. Minnie Baylor-Henry, J.D.
Ms. Minnie Baylor-Henry, J.D.
Independent Director
Independent Director
9.90K
+34.47%
Dr. Phuong Khanh (P. K.) Morrow, M.D.
Dr. Phuong Khanh (P. K.) Morrow, M.D.
Independent Director
Independent Director
3.10K
+450.62%
Mr. Samuel R. (Sam) Leno
Mr. Samuel R. (Sam) Leno
Independent Director
Independent Director
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Ms. Mary Anne Heino
Ms. Mary Anne Heino
Chairman of the Board
Chairman of the Board
584.72K
-4.27%
Mr. Brian A. Markison
Mr. Brian A. Markison
Chief Executive Officer, Director
Chief Executive Officer, Director
232.42K
+35.31%
Ms. Amanda Morgan
Ms. Amanda Morgan
Chief Commercial Officer
Chief Commercial Officer
39.58K
+55.76%
Dr. Jean-Claude Provost, M.D.
Dr. Jean-Claude Provost, M.D.
Chief Scientific Officer
Chief Scientific Officer
38.84K
-31.55%
Dr. James H. (Jim) Thrall
Dr. James H. (Jim) Thrall
Independent Director
Independent Director
35.74K
+7.64%
Ms. Julie H. Mchugh
Ms. Julie H. Mchugh
Lead Independent Director
Lead Independent Director
25.96K
-16.67%
Detalhamento da receita
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Por EmpresaUSD
Nome
Receita
Proporção
PYLARIFY
257.65M
0.00%
DEFINITY
79.21M
0.00%
TechneLite
19.71M
0.00%
Strategic partnerships and other
10.75M
0.00%
Other precision diagnostics
5.44M
0.00%
Radiopharmaceutical oncology
0.00
0.00%
Sem dados
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
PYLARIFY
257.65M
0.00%
DEFINITY
79.21M
0.00%
TechneLite
19.71M
0.00%
Strategic partnerships and other
10.75M
0.00%
Other precision diagnostics
5.44M
0.00%
Radiopharmaceutical oncology
0.00
0.00%
Distribuição de ações
Atualizado em: qua, 14 de mai
Atualizado em: qua, 14 de mai
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
BlackRock Institutional Trust Company, N.A.
11.27%
The Vanguard Group, Inc.
10.10%
Janus Henderson Investors
9.05%
Farallon Capital Management, L.L.C.
8.71%
State Street Global Advisors (US)
3.81%
Other
57.07%
Investidores
Investidores
Proporção
BlackRock Institutional Trust Company, N.A.
11.27%
The Vanguard Group, Inc.
10.10%
Janus Henderson Investors
9.05%
Farallon Capital Management, L.L.C.
8.71%
State Street Global Advisors (US)
3.81%
Other
57.07%
Tipos de investidores
Investidores
Proporção
Investment Advisor/Hedge Fund
53.47%
Investment Advisor
43.79%
Hedge Fund
11.55%
Research Firm
3.19%
Individual Investor
2.27%
Pension Fund
1.94%
Bank and Trust
1.35%
Sovereign Wealth Fund
0.57%
Family Office
0.09%
Participação acionária institucional
Atualizado em: ter, 1 de jul
Atualizado em: ter, 1 de jul
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q2
1027
81.92M
118.40%
-3.35M
2025Q1
1066
83.20M
120.27%
-2.89M
2024Q4
1033
78.65M
114.86%
-4.64M
2024Q3
1003
73.69M
106.06%
-7.92M
2024Q2
959
71.82M
103.63%
-10.29M
2024Q1
912
71.21M
103.87%
-11.25M
2023Q4
868
73.50M
107.32%
-9.24M
2023Q3
828
74.80M
109.31%
-3.81M
2023Q2
790
72.85M
106.61%
-3.94M
2023Q1
733
71.94M
105.47%
-6.73M
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
BlackRock Institutional Trust Company, N.A.
7.79M
11.27%
+17.69K
+0.23%
Mar 31, 2025
The Vanguard Group, Inc.
6.99M
10.1%
-242.63K
-3.36%
Mar 31, 2025
Janus Henderson Investors
6.26M
9.05%
-252.58K
-3.88%
May 30, 2025
Farallon Capital Management, L.L.C.
6.02M
8.71%
+707.00K
+13.30%
Mar 31, 2025
State Street Global Advisors (US)
2.64M
3.81%
-4.26K
-0.16%
Mar 31, 2025
Fidelity Management & Research Company LLC
2.17M
3.14%
+148.84K
+7.36%
Mar 31, 2025
Geode Capital Management, L.L.C.
1.78M
2.57%
+94.57K
+5.62%
Mar 31, 2025
Westfield Capital Management Company, L.P.
1.59M
2.3%
+34.05K
+2.19%
Mar 31, 2025
T. Rowe Price Investment Management, Inc.
1.41M
2.04%
-96.91K
-6.42%
Mar 31, 2025
Reinhart Partners, LLC
1.21M
1.74%
-160.93K
-11.77%
Mar 31, 2025
Ver Mais
ETFs Relacionados
Atualizado em: dom, 6 de jul
Atualizado em: dom, 6 de jul
Nome
Proporção
Harbor Health Care ETF
2.88%
Invesco S&P MidCap 400 GARP ETF
2.64%
Invesco Dorsey Wright Healthcare Momentum ETF
2.28%
SPDR S&P Health Care Equipment ETF
1.83%
Fidelity Stocks for Inflation ETF
1.32%
Janus Henderson US Sustainable Equity ETF
1.26%
Invesco S&P MidCap 400 Pure Growth ETF
1.06%
First Trust Small Cap US Equity Select ETF
1%
Astoria US Quality Kings ETF
0.78%
VictoryShares Free Cash Flow Growth ETF
0.74%
Ver Mais
Harbor Health Care ETF
Proporção2.88%
Invesco S&P MidCap 400 GARP ETF
Proporção2.64%
Invesco Dorsey Wright Healthcare Momentum ETF
Proporção2.28%
SPDR S&P Health Care Equipment ETF
Proporção1.83%
Fidelity Stocks for Inflation ETF
Proporção1.32%
Janus Henderson US Sustainable Equity ETF
Proporção1.26%
Invesco S&P MidCap 400 Pure Growth ETF
Proporção1.06%
First Trust Small Cap US Equity Select ETF
Proporção1%
Astoria US Quality Kings ETF
Proporção0.78%
VictoryShares Free Cash Flow Growth ETF
Proporção0.74%
Dividendo
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados
